CBU
AGL icon

CIBC Bancorp USA’s Agilon Health AGL Stock Holding History

CIBC Bancorp USA’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$33.9K Buy
+1,316
New +$49.7K ﹤0.01% 1438

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CIBC Bancorp USA's AGL Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Agilon Health (AGL) in Q3 2025: 1,316 shares worth $33.9K. The stake represents ﹤0.01% of the portfolio and ranks #1438 among its holdings.

190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • CIBC Bancorp USA held 1,316 shares of Agilon Health worth $33.9K as of Q3 2025.
  • Agilon Health was a new CIBC Bancorp USA position in Q3 2025.
  • Agilon Health made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1438 holding.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.